Single dose metronidazole, tinidazole and ornidazole in the treatment of bacterial vaginosis - a comparative study
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20163220Keywords:
Bacterial vaginosis, Metronidazole, Ornidazole, TinidazoleAbstract
Background: Bacterial vaginosis (BV) is the most common cause of abnormal vaginal discharge. There is a lack of consensus on the etiologic agents or agents associated with BV, due to polymicrobial nature. There is high recurrence rate of BV and it is difficult to treat. Metronidazole is the drug of choice but newer nitroimidazoles are better alternatives with long half-lives and better tolerability.
Methods: This was a prospective, comparative, randomized, single blinded study on 120 diagnosed cases of bacterial vaginosis, with symptomatic or asymptomatic abnormal vaginal discharge. Amsel’s criteria were used to diagnose bacterial vaginosis as well as to assess the response and classify the patients as cured, partially cured and not cured. Statistical analysis was done by Chi square test. The cure rate was compared considering metronidazole cure rate as gold standard.
Results: At 1 week, the cure rate of tinidazole and ornidazole was 89.5% in both the groups, and at 4 weeks, it was 84.5% for both drugs (P <0.001). Metronidazole showed a cure rate of 65.7% at 4 weeks.
Conclusions: Tinidazole and ornidazole have better cure rate as compared to metronidazole in cases of bacterial vaginosis.
References
Koumans EH, Sternberg M, Bruce C, Mc Quillan G, Kendrick J, Sutton M, et al. The prevalence of bacterial vaginosis in the United States, 2001-2004: associations with symptoms, sexual behaviors, and reproductive health. Sex Transm Dis. 2007;34:864-9.
National Family Health Survey 2: 1998-99, (NFHS II), Mumbai. International Institute for Population Sciences. 1999:307-14.
Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol. 1990;163:510–4.
Avonts D, Sercu M, Heyerick P, Vandermeeren I, Meheus A, Piot P. Incidence of uncomplicated genital infections in women using oral contraception or an intrauterine device: a prospective study. Sex Transm Dis. 1990;17:23–9.
Josey W, Schwebke J. The polymicrobial hypothesis of bacterial vaginosis causation: a reassessment. Int J STD AIDS. 2008;19:152–4.
2015 CDC STD Treatment Guidelines. Available at http://www.cdc.gov/std/tg2015/bv.htm. Accessed on 01 August 2016.
Mattila J, Mannisto PT, Mantyla R, Nykanen S, Lamminsivu U. Comparative pharmacokinetics of Metronidazole and Tinidazole as influenced by administration route. Antimicrob Agents Chemother. 1983;23:721-5.
Larsson PG, Forsum U. Bacterial vaginosis–A disturbed bacterial flora and treatment enigma. APMIS. 2005;113:305-16.
Martin C, Bruguerolle B, Mallet MN, Condomines M, Sastre B, Gouin F. Pharmacokinetics and tissue penetration of a single dose of Ornidazole. Antimicrob Agent Chemother. 1990;34:1921-4.
Tripathi KD. antiamoebic and other antiprotozoal drugs In: tripathi M, Essentials of medical pharmacology. 7th Edition. New Delhi. Jaypee Brothers; 2014: 839.
Thulkar J, Kriplani A, Agarwal N. A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis. Indian J Pharmacol. 2012;44:243.
Fredricks DN, Fiedler TL, Thomas KK, Oakley BB, Marrazzo JM. Targeted PCR for detection of vaginal bacteria associated with bacterial vaginosis. J Clin Microbiol. 2007;45(10):3270-6.
Bradshaw CS, Morton AN, Garland SM, Morris MB, Moss LM, Fairley CK. Higher-risk behavioral practices associated with bacterial vaginosis compared with vaginal candidiasis. Obstet Gynecol. 2005;106:105–14.
Hellberg D, Nilsson S, Mardh PA. Bacterial vaginosis and smoking. Int J STD AIDS. 2000;11:603–6.
Mbizvo ME, Musya SE, Stray-Pedersen B, Chirenje Z, Hussain A. Bacterial vaginosis and intravaginal practices: association with HIV. Cent Afr J Med. 2004;50:41–6.
Hutchinson KB, Kip KE, Ness RB. Vaginal douching and development of bacterial vaginosis among women with normal and abnormal vaginal microflora. Sex Transm Dis. 2007;34:671–5.
Bukusi EA, Cohen CR, Meier AS, Waiyaki PG, Nguti R, Njeri JN, et al. Bacterial vaginosis: risk factors among Kenyan women and their male partners. Sex Transm Dis. 2006;33:361–7.
Brandt M, Abels C, May T, Lohmann K, Schmidts-Winkler I, Hoyme B. Intravaginally applied metronidazole is as effective as orally applied in the treatment of bacterial vaginosis, but exhibits significantly less side effects. Eur J Obstet Gynecol Reprod Biol. 2008;141:158–62.
Kurt O, Girginkardeşler N, Balcioğlu IC, Ozbilgin A, Ok UZ. A comparison of metronidazole and single‑dose ornidazole for the treatment of dientamoebiasis. Clin Microbiol Infect. 2008;14:601‑4.
Carmona O, Silva H, Acosta H. Vaginitis due to Gardenerella vaginalis treatment with tinidazole. Curr Ther Res. 1983;22:898–904.
Mohanty KC, Deighton R. Comparison of 2 g single dose of metronidazole, nimorazole and tinidazole in the treatment of vaginitis associated with Gardnerella vaginalis. J Antimicrob Chemother. 1987;19:393–9.
Austin MN, Meyn LA, Hillier SL. Susceptibility of vaginal bacteria to metronidazole and tinidazole. Anaerobe. 2006;12:227–30.
Armstrong NR, Wilson JD. Tinidazole for bacterial vaginosis. International Journal of Women’s Health. 2009;1:59-65.
Nailor MD, Sobel JD. Tinidazole for bacterial vaginosis. Expert Review of Anti-infective Therapy. 2007;5(3):343–8.
Schindler EM, Thamm H, Ansmann EB, Sarnow E, Schindler AE. Treatment of bacterial vaginitis. Multicenter, randomized, open study with tinidazole in comparision with metronidazole. Fortschr Med. 1991;109:138‑40.
Buranawarodomkul P, Chandeying V, Sutthijumroon S. Seven day metronidazole versus single dose tinidazole as therapy for nonspecific vaginitis. J Med Assoc Thai. 1990;73:283–7.
Sanz F, Hernanz A, Sancher E. Comparative trial of metronidazole versus tinidazole in the treatment of nonspecific vaginitis. Rev Esp Obst y Gin. 1985;44:717–20.
Schwebke JR, Desmond RA. Tinidazole versus Metronidazole for the Treatment of Bacterial Vaginosis. Am J Obstet Gynecol. 2011;204(3):211.
Livengood CH, Ferris DG, Wiesenfeld HC, Hillier SL, Soper DE, Nyirjesy P, et al. Effectiveness of Two Tinidazole Regimens in Treatment of Bacterial Vaginosis: A Randomized Controlled Trial. Obstetrics & Gynaecology. 2007;110:302–9.
Rosenblatt JE, Edson RS. Symposium on antimicrobial agents. Metronidazole. Mayo Clin Proc. 1987;62:1013-7.
Erkkola R, Jarvinen H. Single dose of Ornidazole in the treatment of bacterial vaginosis. Ann Chir Gynaecol Suppl. 1987;202:94-6.
